title: Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function.
abstract: OBJECTIVE
  Patients with severe left ventricular (LV) dysfunction have a poor long term survival despite complete surgical revascularization. Recent data suggests that the use of Implantable Cardioverter-Defibrillator (ICD) improves survival in patients with severe LV dysfunction. We compared the survival impact of ICD implantation in patients with severe LV dysfunction who underwent CABG.
  
  
  METHODS
  Between January 1996 and August 2004, 305 patients with LV ejection fraction (EF) < or = 25% had CABG surgery at our institution. Demographics of patients who had received an ICD (ICD+) in the post -operative period was compared to those without ICD (ICD-). Survival was evaluated by the Kaplan-Meier method.
  
  
  RESULTS
  Of the entire group, 35 (11.5%) patients received an ICD with a median of 2 (+/-2) years after CABG. Indication for ICD implantation was clinical evidence of non sustained ventricular tachycardia (NSVT). There were no differences between the 2 groups with respect to age, gender, NYHA classification, number of bypasses, or other co-morbidities. Survival at 1, 3 and 5 years was 88%, 79%, and 67% for the ICD- group compared to 94%, 89% and 83% for the ICD+ group, respectively (figure, p < 0.05).
  
  
  CONCLUSIONS
  Implantation of ICD after CABG confers improved short and long term survival benefit to patients with severe LV dysfunction. Prophylactic ICD implantation in the setting of severe LV dysfunction and CABG surgery should be considered.
authors.affiliation: Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St Louis, USA. aldadaha@wustl.edu
authors.forename: Ashraf S
authors.initials: AS
authors.lastname: Al-Dadah
authors.forename: Rochus K
authors.initials: RK
authors.lastname: Voeller
authors.forename: Paymon
authors.initials: P
authors.lastname: Rahgozar
authors.forename: Jennifer S
authors.initials: JS
authors.lastname: Lawton
authors.forename: Marc R
authors.initials: MR
authors.lastname: Moon
authors.forename: Michael K
authors.initials: MK
authors.lastname: Pasque
authors.forename: Ralph J
authors.initials: RJ
authors.lastname: Damiano
authors.forename: Nader
authors.initials: N
authors.lastname: Moazami
mesh_terms: D000368:Aged; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000150:complications / Q000401:mortality / Q000601:surgery*; D017147:Defibrillators, Implantable; D004554:Electric Countershock; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013318:Stroke Volume; D015996:Survival Rate; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000401:mortality* / Q000628:therapy*